Grail, Inc. balance sheet
At the end of fiscal 2025, Grail, Inc. had total assets of $2.92bn, total liabilities of $344m and shareholders' equity of $2.58bn. It held $250m in cash against $0 of debt: net cash of $250m.
Balance sheet
| Fiscal year | 2022Jan 2023 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | 242 | 97 | 214 | 250 | 56 |
| Receivables | — | 17 | 20 | 18 | 20 |
| Total current assets | — | 156 | 820 | 954 | 915 |
| Goodwill | 1,497 | 889 | 0 | — | — |
| Total assets | — | 3,914 | 2,983 | 2,922 | 2,844 |
| Accounts payable | — | 20 | 5 | 2 | 7 |
| Total current liabilities | — | 164 | 77 | 80 | 84 |
| Total debt | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | — | 268 | 480 | 344 | 301 |
| Shareholders' equity | — | — | 2,503 | 2,578 | 2,543 |
| Net debt (negative = net cash) | −242 | −97 | −214 | −250 | −56 |
| Shares outstanding | — | — | 34m | 40m | 45m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | — | 20 | 19 | 16 | 16 | 18 | 20 | 20 |
| Total current assets | 910 | 820 | 728 | 652 | 589 | 954 | 877 | 915 |
| Goodwill | 0 | 0 | — | — | — | — | — | — |
| Total assets | 3,118 | 2,983 | 2,848 | 2,703 | 2,601 | 2,922 | 2,803 | 2,844 |
| Accounts payable | — | 5 | 6 | 6 | 3 | 2 | 5 | 7 |
| Total current liabilities | 94 | 77 | 75 | 71 | 77 | 80 | 75 | 84 |
| Total liabilities | 530 | 480 | 434 | 388 | 361 | 344 | 303 | 301 |
| Shareholders' equity | 2,588 | 2,503 | 2,414 | 2,315 | 2,240 | 2,578 | 2,501 | 2,543 |
| Shares outstanding | 33m | 34m | 35m | 36m | 36m | 40m | 41m | 45m |
Compare with peers
- Pacific Biosciences Of California, Inc. balance sheet
- Quanterix Corp balance sheet
- Cryoport, Inc. balance sheet
- Cytek Biosciences, Inc. balance sheet
- Maravai Lifesciences Holdings, Inc. balance sheet
Head to head: GRAL vs PACBGRAL vs QTRXCYRX vs GRAL
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies